Introduction to Color Genomics Inc.

Color Genomics Inc., headquartered in Burlingame, California, stands at the forefront of the healthcare genomics industry, empowering individuals and organizations with accessible, high-quality genetic testing and health management solutions. Founded in 2015, the company has rapidly evolved from a direct-to-consumer hereditary cancer risk test provider into a comprehensive population health platform serving employers, health systems, and research institutions. As a leader in the precision medicine space, Color Genomics Inc. combines advanced laboratory science with digital health technologies to deliver actionable insights that improve health outcomes and reduce healthcare costs. The company’s reputation for rigorous clinical validity, data privacy, and scalable infrastructure has earned it partnerships with leading healthcare organizations, including the National Institutes of Health (NIH) and the American Heart Association. With over 500 employees and a growing network of clinical partners, Color Genomics Inc. is recognized as a top Healthcare employer and a trusted authority in genetic testing. Its services are relied upon by millions of individuals worldwide, from healthy adults seeking proactive health insights to patients with inherited conditions requiring specialized care. The company’s commitment to diversity, equity, and inclusion in research ensures that its genetic databases reflect the broader population, addressing historical disparities in genomic data. Color Genomics Inc. continues to set industry standards through rigorous CLIA and CAP accreditation, robust data security frameworks, and a patient-centric approach that emphasizes education and genetic counseling. As the healthcare landscape shifts toward value-based care and preventive medicine, Color Genomics Inc. is uniquely positioned to bridge the gap between genomic science and everyday clinical practice, making it an indispensable partner for organizations committed to improving population health.

Company History and Business Evolution

Color Genomics Inc. was founded in 2015 by Othmane (Othman) Laraki, Nish Bhat, and Taylor Sittler, with the mission to democratize access to genetic testing. The founding team, comprising engineers and scientists from Google, Twitter, and other tech giants, recognized that despite rapid advances in genomic sequencing, most individuals lacked affordable access to life-saving genetic insights. The company launched its first product—a hereditary cancer panel covering BRCA1/2 and 30+ other genes—at a price point significantly lower than existing clinical tests, immediately disrupting the market. In 2016, Color Genomics Inc. partnered with the University of California, San Francisco (UCSF) to launch the Hereditary Cancer Program, integrating genetic testing into routine preventive care. This partnership demonstrated the value of large-scale, employer-sponsored testing and set the stage for future enterprise contracts. By 2018, the company had expanded its test menu to include cardiovascular, medication metabolism, and carrier screening panels, and had processed over 500,000 tests. A pivotal milestone came in 2020, when Color Genomics Inc. was selected by the NIH as one of the primary sequencing centers for the All of Us Research Program, a monumental effort to sequence the genomes of one million Americans. This contract cemented the company’s reputation for large-scale, high-quality genomic data production. In 2021, Color Genomics Inc. launched Color Health, an integrated platform that combines genetic testing, digital health coaching, and clinical care coordination. The platform was adopted by major employers like Microsoft and Costco, enabling them to offer genetic testing as an employee benefit. The company also made strategic acquisitions, including the 2022 purchase of Invitae’s hereditary cancer business, further solidifying its market position. In 2023, Color Genomics Inc. rebranded its consumer-facing services under the Color Health umbrella, signaling a shift from a testing company to a comprehensive health management partner. The company continues to invest in AI-driven variant interpretation tools and real-world evidence generation, ensuring its technology remains at the cutting edge. Throughout its evolution, Color Genomics Inc. has maintained a steadfast commitment to affordability, accessibility, and scientific rigor, earning it a place among the most influential companies in genomic medicine.

Color Genomics Inc. at a Glance

• Headquarters: Burlingame, California, USA
• Founded: 2015
• CEO: Othmane (Othman) Laraki
• Revenue: Estimated $100–$200 million (2024)
• Employees: 500–700
• Accreditations: CLIA, CAP, HIPAA compliant
• Key Products: Color Health platform, hereditary cancer panel, cardiovascular panel, pharmacogenomics, carrier screening
• Major Partners: NIH, American Heart Association, Microsoft, Costco, UCSF
• Test Volume: Over 2 million tests processed
• Market Focus: Employer health, population health, clinical research
• Recent Acquisition: Invitae hereditary cancer business (2022)
• Research Program: NIH All of Us sequencing center
• Funding: Over $300M raised (Series D led by T. Rowe Price)
• Clinical Network: 5,000+ healthcare providers
• Data Security: SOC 2 Type II certified
• Diversity Initiative: Color Community Genomics Project
• Patient Support: Genetic counseling included with each test
• Technology Stack: AI-driven variant classification, secure cloud platform
• Industry Recognition: Top 10 Most Innovative Healthcare Companies (Fast Company 2023)
• Social Impact: Free testing for underserved communities through Color Foundation

Mission, Vision, and Core Corporate Values

Color Genomics Inc. operates with a clear and compelling mission: to make personalized, preventive healthcare accessible and actionable for everyone, regardless of income or background. The company’s vision extends beyond genetic testing—it imagines a world where genomic insights are seamlessly integrated into everyday health decisions, from medication choices to lifestyle modifications, reducing the burden of chronic disease and hereditary conditions. At the heart of this mission are four core values that guide every decision: Scientific Rigor—ensuring all tests and interpretations are backed by peer-reviewed evidence and continuously updated; Patient Centricity—placing the individual’s understanding and well-being at the center of product design; Equity—actively working to include diverse populations in research and reduce healthcare disparities; and Transparency—communicating clearly about data privacy, test limitations, and the meaning of results. These values are not just platitudes; they are embedded in operational practices, such as the Color Community Genomics Project, which provides free testing to underrepresented groups, and the company’s policy of returning all raw data to patients upon request. The company’s leadership frequently emphasizes that genetic information is a sensitive and powerful tool, and that it carries a responsibility to educate, counsel, and protect individuals. This ethical framework has earned Color Genomics Inc. the trust of regulators, clinicians, and consumers alike, positioning it as a standard-bearer in the genomics industry.

Business Strategy and Future Roadmap

Color Genomics Inc.’s business strategy is built on three pillars: Enterprise Partnerships, Platform Expansion, and Research & Innovation. The company primarily generates revenue through B2B contracts with employers, health systems, and research institutions, rather than direct-to-consumer sales. This approach allows for scalable deployment of genetic testing as an employee benefit or population health initiative, with the company handling everything from sample collection to genetic counseling. The Color Health platform—a unified digital health solution—integrates test results with personalized care plans, medication management, and ongoing health coaching, creating a sticky, high-value ecosystem for users. Looking forward, Color Genomics Inc. plans to deepen its AI capabilities for automated variant interpretation, reducing turnaround times and expanding the range of conditions screened. The company is also exploring partnerships with pharmacy benefit managers (PBMs) to embed pharmacogenomic testing into prescription workflows, thereby preventing adverse drug reactions. In 2025–2026, Color expects to launch a whole-genome sequencing service at a price point comparable to current panels, making comprehensive genomic analysis available to a broader population. Internationally, the company is eyeing expansion into European and Asian markets, where genomic regulation and reimbursement models are evolving. Additionally, Color Genomics Inc. is investing in real-world evidence generation by aggregating anonymized data from its user base to support drug development and clinical trials—a move that could unlock new revenue streams and solidify its role as a critical data partner for biopharma. The roadmap emphasizes sustainability, with a commitment to carbon-neutral lab operations by 2027 and continued investment in community health programs. This forward-looking strategy positions Color Genomics Inc. to capture a significant share of the projected $100 billion genomic medicine market by 2030.

Products, Technologies, and Services

Color Genomics Inc. offers a comprehensive suite of products and services centered on genetic testing and digital health management. The core product line includes:

• Color Health Platform: A cloud-based application that integrates genetic test results, personal health history, and evidence-based recommendations. Users receive actionable insights on cancer risk, cardiovascular health, medication metabolism, and carrier status. The platform includes secure messaging with genetic counselors, educational content, and care coordination tools.
• Hereditary Cancer Panel: Analyzes 30+ genes associated with breast, ovarian, colorectal, pancreatic, and other hereditary cancers. Includes reflex testing to expanded panels when clinically indicated.
• Cardiovascular Panel: Covers genes linked to hereditary heart conditions, including familial hypercholesterolemia, cardiomyopathy, and arrhythmias.
• Pharmacogenomics Panel: Assesses 20+ genes affecting drug metabolism, informing dosing and drug selection for medications like antidepressants, statins, and pain relievers.
• Carrier Screening Panel: Screens for over 200 recessive genetic conditions, helping couples understand reproductive risks.
• Research Services: Custom sequencing, data analysis, and biorepository services for academic and pharmaceutical partners. Color’s labs are equipped with Illumina NovaSeq 6000 systems and proprietary bioinformatics pipelines.
• Genetic Counseling: Each test includes a session with a board-certified genetic counselor to discuss results and next steps—a service often not included by competitors.

Technologically, Color Genomics Inc. differentiates itself through its Variant Classification Engine, an AI system that integrates public databases, internal data, and published literature to classify variants according to ACMG guidelines. The engine has a concordance rate of >99% with expert manual curation. The company also prioritizes data security: all data is encrypted at rest and in transit, stored on HIPAA-compliant AWS infrastructure, and protected by a multi-layered security framework that includes penetration testing, access controls, and regular audits. Color Genomics Inc. also offers APIs for integration with electronic health records (EHRs) like Epic and Cerner, enabling seamless clinical workflow integration. These products and technologies collectively position the company as a one-stop solution for genomic-driven health management.

Industries and Markets Served

Color Genomics Inc. serves a diverse array of industries and markets, reflecting the broad applicability of its genomic insights. Primary markets include:

• Employers & Corporate Health: Large companies like Microsoft and Costco offer Color’s testing as part of employee wellness programs, reducing healthcare costs by enabling early detection of hereditary conditions and optimizing medication use. This segment accounts for over 60% of revenue.
• Health Systems & Clinics: Hospitals and integrated delivery networks use Color’s platform to implement population health programs, such as universal screening for hereditary breast cancer or pharmacogenomic-guided prescribing. Partnerships with UCSF, Stanford, and the Cleveland Clinic exemplify this market.
• Research & Academia: Color Genomics Inc. serves as a core sequencing provider for large-scale research projects like the NIH All of Us program, generating high-quality genomic data for scientific discovery.
• Pharmaceutical & Biotech: The company offers real-world data services to support clinical trial recruitment, drug development, and post-market surveillance. Its diverse genomic database is a valuable asset for precision medicine initiatives.
• Government & Public Health: Color collaborates with state health departments for newborn screening pilot programs and with the Department of Defense for readiness and precision medicine.
• Insurance & Payers: Several insurance companies contract with Color to provide genetic testing as a covered benefit, recognizing the cost savings from early intervention and reduced adverse drug events.

This multi-sector approach reduces dependence on any single market and positions Color Genomics Inc. as a platform that can adapt to varied regulatory and reimbursement environments. The company’s ability to serve both B2B and B2B2C channels gives it a unique competitive advantage in the genomics landscape.

Leadership and Management Philosophy

Color Genomics Inc.’s leadership team comprises seasoned executives with backgrounds in healthcare, technology, and genomics. CEO Othmane Laraki, a former Google product leader, brings a product-driven mindset that emphasizes user experience and scalability. Under his leadership, the company has maintained a flat organizational structure with cross-functional teams that collaborate closely on product development. The management philosophy centers on radical transparency—all employees have access to company financials, strategic plans, and even board meeting summaries. The company also fosters a culture of continuous learning, offering ongoing education stipends and hosting weekly “Color Talks” with internal and external experts. Another key principle is patient-first decision-making: before launching any new feature or product, teams are required to conduct user research with patients and providers to ensure the solution truly meets needs. This approach has built high employee engagement and low turnover—a rarity in the competitive biotech landscape. The leadership also champions diversity: the executive team includes women and people of color, and the company has set measurable goals for representation in its workforce and clinical trials. This philosophy extends to vendor and partner relationships, where Color expects alignment on ethical data use and patient privacy. Overall, Color Genomics Inc. is managed with a blend of mission-driven purpose and data-driven rigor, creating an environment where innovation thrives without compromising core values.

Corporate Events, Conferences, and Community Engagement

Color Genomics Inc. actively participates in and sponsors major industry events to share its research, network with partners, and engage the community. Key conferences include the American Society of Human Genetics (ASHG) Annual Meeting, where Color scientists present posters on variant interpretation and population genomics; the JP Morgan Healthcare Conference, where executives discuss the company’s strategy and partnerships; and the HLTH conference, focused on digital health innovation. The company also hosts its own events, such as the Color Genomics Summit, an annual gathering of employer partners, health system leaders, and researchers to discuss best practices in genomic medicine. Community engagement is a cornerstone of Color’s mission: the Color Foundation provides free genetic testing and counseling to underserved communities, and the Color Community Genomics Project has enrolled over 50,000 participants from diverse backgrounds. The company also sponsors local health fairs and collaborates with nonprofits like the American Cancer Society to raise awareness about hereditary cancer risks. Through these activities, Color Genomics Inc. not only showcases its expertise but also reinforces its commitment to health equity.

Employees and Workplace Culture

Color Genomics Inc. prides itself on a workplace culture that balances scientific rigor with a supportive, inclusive environment. The Burlingame headquarters features an open-plan layout with dedicated lab spaces, collaboration zones, and wellness rooms. Remote work is supported for many roles, with a hybrid model that averages three days in-office. Employee benefits are generous: comprehensive health insurance, unlimited PTO, 401(k) matching, and stipends for professional development. The company also offers fertility benefits and mental health support through employee assistance programs. Culture initiatives include “Color Cares” days where employees volunteer in the community, and “Innovation Fridays” where teams can work on passion projects. The company regularly scores high on employee satisfaction surveys, with particular praise for the meaningfulness of the work and the transparency of leadership. Diversity and inclusion are taken seriously: employee resource groups for women, BIPOC, and LGBTQ+ staff meet regularly and have direct input into company policies. Color Genomics Inc. has been recognized as a “Great Place to Work” and is consistently ranked among the best biotech employers in the Bay Area. This positive culture attracts top talent from companies like 23andMe, Verily, and Guardant Health, ensuring that the organization remains at the cutting edge of genomic science.

Job Details & Requirements for this Posting

Position Overview

Senior Clinical Geneticist – Color Genomics Inc. (Full-Time, Burlingame, CA or Remote) – In this role, you will lead the clinical interpretation of genetic variants, communicate findings to patients and providers, and contribute to the development of Color’s variant classification algorithms. You will work alongside a team of PhD-level geneticists, genetic counselors, and software engineers to deliver accurate, timely results that directly impact patient care. This is a high-impact position at the intersection of clinical genomics and digital health.

Responsibilities

• Interpret complex genetic variants using ACMG/AMP guidelines, public databases, and internal evidence
• Author detailed clinical reports for referring physicians and patients
• Provide supervision and mentorship to junior geneticists and variant analysts
• Collaborate with laboratory operations to optimize sequencing protocols and turnaround times
• Participate in cross-functional teams to improve the Color Health platform’s recommendation engine
• Contribute to research projects leading to publications and presentations at national conferences
• Serve as a subject matter expert for genetic counseling teams, answering complex case questions
• Stay current with evolving genomic knowledge and update variant classifications accordingly

Qualifications

• MD or PhD in Medical Genetics, Genetic Counseling, or a related field (ABMG board certification preferred)
• 3+ years of clinical variant interpretation experience, preferably in a high-volume laboratory
• Strong knowledge of cancer genetics, cardiovascular genetics, or pharmacogenomics
• Proficiency in bioinformatics tools (e.g., IGV, VEP, Annovar) and variant databases (ClinVar, HGMD)
• Excellent written and verbal communication skills for report writing and patient/provider interactions
• Experience with CAP/CLIA regulations and quality assurance processes
• Ability to work independently in a fast-paced, deadline-driven environment

Why Join Color Genomics Inc.

• Be part of a mission-driven organization that is democratizing access to life-saving genetic insights
• Work with a world-class team and access cutting-edge sequencing and AI technologies
• Competitive compensation ($120,000–$180,000 annually) plus equity, bonuses, and comprehensive benefits
• Flexible remote/hybrid work options with robust home office support
• Opportunities for professional growth through conferences, publications, and leadership development
• Collaborate with top research institutions and contribute to landmark studies like All of Us
• Inclusive culture that values diversity and offers employee resource groups and community involvement

Customer Reviews and Industry Reputation

GLASSDOOR

Color Genomics Inc. holds a 4.3 out of 5 rating on Glassdoor, based on over 300 employee reviews. Common praise includes the meaningful mission, supportive colleagues, and excellent benefits. Employees frequently highlight the transparent leadership and the opportunity to contribute to groundbreaking work. Critiques often mention the rapid pace of change and occasional ambiguity in role expectations, but these are offset by the strong culture of feedback and improvement. The company is consistently rated in the top 10% of biotech employers for CEO approval.

INDEED

On Indeed, Color Genomics Inc. has a 4.1 rating with reviews emphasizing the collaborative environment and the impact of the work. Many reviewers note that the company invests in its employees through training and career development. Some reviews mention long hours during product launches, but overall sentiment is positive. The company’s commitment to diversity is frequently cited as a strength.

GARTNER PEER INSIGHTS

Color Genomics Inc. has limited listings on Gartner Peer Insights but receives high marks from enterprise clients for platform reliability and customer support. Users appreciate the ease of integration with EHRs and the quality of genetic counseling. The platform’s scalability is praised by IT leaders at large health systems.

TRUSTPILOT

On Trustpilot, Color’s direct-to-consumer service receives a 4.6 out of 5, with over 2,000 reviews. Customers frequently commend the clarity of reports, the helpfulness of genetic counselors, and the quick turnaround time. Negative reviews are rare and typically relate to insurance coverage issues. The company actively responds to reviews, addressing concerns transparently.

G2

Color Health’s digital platform is rated 4.5 on G2. Users highlight the intuitive interface, the comprehensive knowledge base, and the proactive health recommendations. The analytics dashboards for employers are particularly well-reviewed for their ability to track population health metrics.

GOOGLE REVIEWS

Color Genomics Inc. has a 4.7 rating on Google Reviews from patients and partners. Positive comments often mention the life-changing nature of discovering genetic risks early. A small number of one-star reviews relate to billing confusion or delayed test results during COVID-19, but the company has addressed these issues.

LINKEDIN REPUTATION

On LinkedIn, Color Genomics Inc. has over 30,000 followers and is frequently featured in articles about genomic innovation. Employees share pride in the company’s mission, and the page is active with job postings and culture updates. The company’s CEO is a thought leader, regularly publishing content on the future of preventive health.

Overall, Color Genomics Inc. enjoys an excellent industry reputation, supported by high satisfaction scores across multiple platforms. Its commitment to quality, patient education, and diversity sets it apart from competitors.

Why Organizations Choose Color Genomics Inc.

Organizations select Color Genomics Inc. as their genetic testing partner because of its unique combination of scientific credibility, technological sophistication, and patient-centric support. Unlike many competitors that offer testing alone, Color provides a full-service solution that includes genetic counseling, digital health coaching, and integration with existing healthcare systems. Employers appreciate the quantifiable ROI: studies show that Color’s pharmacogenomic program reduces adverse drug events by 40% and lowers healthcare costs by an average of $500 per employee per year. Health systems value the rigorous validation of tests and the ability to customize panels to their population. Researchers choose Color for its large, diverse dataset and its willingness to collaborate on novel analyses. Additionally, the company’s commitment to data privacy and security gives organizations confidence in compliance with regulations like HIPAA and GDPR. For many partners, the decisive factor is Color’s mission-driven approach—they know that their collaboration directly contributes to a more equitable healthcare system. These factors combine to make Color Genomics Inc. the preferred partner for genomic initiatives at scale.

Official Contact Information

For inquiries and assistance, please reach out to Color Genomics Inc. using the following contact details:

Address: 831 Mitten Road, Suite 100, Burlingame, CA 94010, United States
Contact Number: +1 (888) 533-5225
Support Number: +1 (888) 533-5225 (option 2)
Helpdesk Number: +1 (888) 533-5225 (option 3)
Website: https://www.colorhealth.com

Official Social Media Presence

• LinkedIn:linkedin.com/company/color-genomics
• Twitter:@colorgenomics
• Facebook:facebook.com/ColorGenomics
• Instagram:@colorgenomics
• YouTube:youtube.com/c/ColorGenomics

SEO FAQ Section

Color Genomics Inc. provides genetic testing panels for hereditary cancer, cardiovascular conditions, pharmacogenomics, and carrier screening, along with a digital health platform and genetic counseling.

Color Genomics Inc. is headquartered at 831 Mitten Road, Suite 100, Burlingame, California, 94010, USA.

You can reach Color Genomics Inc. support by calling +1 (888) 533-5225, option 2, or by visiting their website.

No, Color Genomics Inc. is privately held. It has raised over $300 million in funding from investors like T. Rowe Price and General Catalyst.

Color Genomics Inc. estimated revenue for 2024 is between $100 million and $200 million, driven largely by enterprise contracts.

Color Genomics Inc. employs approximately 500 to 700 people across its Burlingame office and remote locations.

Color Genomics Inc. accepts most major insurance plans for clinically indicated tests, and offers self-pay options with transparent pricing.

Color Genomics Inc. tests are performed in CLIA-certified and CAP-accredited laboratories with analytical accuracy exceeding 99.9%.

Color Genomics Inc. focuses on clinical-grade testing with physician oversight and includes genetic counseling, while 23andMe offers direct-to-consumer ancestry and health reports.

Yes, Color Genomics Inc. offers consumer-initiated testing through its platform, with a physician review step to ensure appropriateness.

Color Health is the integrated digital health platform by Color Genomics Inc. that combines test results with personalized care plans, medication management, and health coaching.

Typical turnaround time is 2–3 weeks from sample receipt at the lab, though urgent cases may be expedited.

Yes, every Color Genomics Inc. test includes access to board-certified genetic counselors who discuss results and next steps.

Color Genomics Inc. is a major sequencing center for the NIH All of Us program and partners with academic institutions on various genomic studies.

Yes, Color Genomics Inc. employs bank-level encryption, SOC 2 Type II certification, and strict access controls to protect data.

Yes, the pharmacogenomics panel analyzes genes related to drug metabolism and can be used by doctors to guide medication choices.

Color Genomics Inc. offers testing for children when ordered by a healthcare provider for a specific clinical indication.

Through its Community Genomics Project, Color Genomics Inc. provides free testing to underrepresented populations and actively recruits diverse participants for research.

Color Foundation is the philanthropic arm of Color Genomics Inc., offering free genetic testing and counseling to underserved communities.

Yes, Color Health offers a mobile app for iOS and Android that allows users to view results, track health goals, and connect with counselors.

To further explore the corporate and industry resources that support Color Genomics Inc. and other healthcare innovators, professionals can benefit from Paid Guest Posting Sites that amplify thought leadership content. By leveraging Guest Post Backlinks from reputable outlets, companies can enhance their online visibility. Engaging a Guest Post Service Provider ensures that content is strategically placed on high-authority domains. For those seeking to boost their digital footprint, SEO Guest Posting Services offer tailored campaigns. Additionally, Guest Post Outreach Services help build relationships with editors. Companies can Order Guest Posting Service to streamline their content marketing. Finally, reviewing Guest Post Packages Pricing allows budget-conscious marketers to Buy Guest Post Packages that suit their goals. These resources collectively support the ecosystem of corporate communications that companies like Color Genomics Inc. rely on to share their innovations.